HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024: Q3 2024
Type / Class: Debt / NOTE 1.000% 8/1
Principal, excl. options Q3 2024: 680M
Holdings value Q3 2024: $810M
Value change Q3 2024: +$105M
Grand Portfolio weight change Q3 2024: +0%
Number of holders: 74
Number of buys Q3 2024: 31
Number of sells Q3 2024: -30
Average buys Q3 2024 %: +0.001%
Average sells Q3 2024 %: -0.001%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q3	$680M	$810M	+$105M	$1.19	75
2024 Q2	$24B	$717M	-$3.71M	$1.11	72
2024 Q1	$623M	$607M	-$28.9M	$0.97	69
2023 Q4	$658M	$615M	+$10.1M	$0.93	70
2023 Q3	$644M	$608M	+$606M	$0.94	62